When this occurs, the PI3K/AKT pathway is noticeably inactivated, and ADAMTS9-mediated downregulation of AKT and PI3K phosphorylation is attenuated, thereby promoting GC progression (20). The gene discussed is ADAMTS9; the disease is gastric cancer.